染色体解析が予後の予測に有用であった多発性筋炎/皮膚筋炎合併B型慢性肝炎に発症した肝癌切除例
スポンサーリンク
概要
- 論文の詳細を見る
It is well known that prognosis of hepatoceller carcinoma (HCC) is not favorite compared to other types of human cancers and a bunch of genetic and epigenetic alterations are involved during development of this tumor. We present here about one HCC patient with chronic hepatitis B and polymyositis/dermatomyositis. Initially, he had a surgical resection for treatment of HCC because tumor was solitary and curable for it's size, but showed an aggressive disease course thereafter. We analyzed the chromosomal alterations of this HCC tissue using polymerase chain reaction-based methods and found several chromosomal alterations including losses on l6q, 17p, which were reportedly associated wide poor prognosis of this disease. He died one year after surgical treatment because of intrahepatic and lymphnode recurrence in spite of various treatments for HCC. This result suggested that accumulation of chromosomal alterations could be a useful predictor for disease aggressiveness and poor prognosis after curative treatment of HCC.
- 京都大学医学部保健学科の論文
著者
関連論文
- HP-104-3 当院における大腸癌肝転移全身化学療法施行症例の検討 : 肝切除への影響と治療成績(大腸(肝転移1),ハイブリッドポスター,第109回日本外科学会定期学術集会)
- 21-P2-213 進行膵がんに対するTS-1とGemcitabine併用療法時の骨髄抑制に関する調査(がん薬物療法(外来化学療法),来るべき時代への道を拓く)
- 遺伝子異常と肝発癌 肝発癌における遺伝子異常 癌抑制遺伝子異常 (肝癌--基礎・臨床研究のアップデート) -- (肝癌の発生・進展機序)
- 染色体解析が予後の予測に有用であった多発性筋炎/皮膚筋炎合併B型慢性肝炎に発症した肝癌切除例
- 3.肝細胞癌の遺伝子異常
- 進行肝細胞癌に対するソラフェニブ投与例におけるSDの持続期間と生存期間の検討
- 進行肝細胞癌患者に対する分子標的薬(ソラフェニブ)投与における治療効果判定基準の比較